Clinical Trials Directory

Trials / Unknown

UnknownNCT02571881

Opioid Induced Bowel Dysfunction in Patients Undergoing Cesarean Section

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
57 (actual)
Sponsor
Kuopio University Hospital · Academic / Other
Sex
Female
Age
18 Years – 45 Years
Healthy volunteers
Not accepted

Summary

Constipation is common in pregnant women. Surgery, anaesthesia and opioid analgesics may further impair bowel function. The aim of the present study was to evaluate if oxycodone-naloxone combination compared to oxycodone reduced bowel dysfunction in patients undergoing caesarean section.

Conditions

Interventions

TypeNameDescription
PROCEDURECaesarean sectionAfter caesarean section oxycodone or oxycodone-naloxone prolonged release tablet twice a day is started for pain medication
DRUGOxycodone
DRUGoxycodone-naloxone

Timeline

Start date
2012-10-01
Primary completion
2023-12-01
Completion
2023-12-01
First posted
2015-10-08
Last updated
2023-03-16

Locations

1 site across 1 country: Finland

Source: ClinicalTrials.gov record NCT02571881. Inclusion in this directory is not an endorsement.

Opioid Induced Bowel Dysfunction in Patients Undergoing Cesarean Section (NCT02571881) · Clinical Trials Directory